|
注册号: Registration number: |
ChiCTR1900027474 |
|
最近更新日期: Date of Last Refreshed on: |
2021-08-27 19:06:42 |
|
注册时间: Date of Registration: |
2019-11-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
耳贴磁珠穴位疗法在新生儿重症监护病房常规操作中镇痛效果评价 |
|
Public title: |
Magnetic auriculoacupuncture for pain relief in neonates undergoing routine procedures in the NICU |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
耳贴磁珠穴位疗法在新生儿重症监护病房常规操作中镇痛效果评价:多中心、三盲临床对照研究 |
|
Scientific title: |
Magnetic auriculoacupuncture for pain relief in neonates undergoing routine procedures in the NICU: protocol for a multicenter, triple-blinded, randomized controlled study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
ChiMCTR1900025344 |
|
申请注册联系人: |
苏雅洁 |
研究负责人: |
李龙 |
|
Applicant: |
Yajie Su |
Study leader: |
Long Li |
|
申请注册联系人电话: Applicant telephone: |
+86 13609984922 |
研究负责人电话:
Study leader's |
+86 13909921138 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yajiesu922@163.com |
研究负责人电子邮件: Study leader's E-mail: |
lilong65@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
新疆维吾尔自治区乌鲁木齐市天山区天池路91号 |
研究负责人通讯地址: |
新疆维吾尔自治区乌鲁木齐市天山区天池路91号 |
|
Applicant address: |
91 Tianchi Road, Tianshan District, Urumqi, Xijiang, China |
Study leader's address: |
91 Tianchi Road, Tianshan District, Urumqi, Xijiang, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
新疆维吾尔自治区人民医院 |
||
|
Applicant's institution: |
People's Hospital of Xinjiang Uygur Autonomous Region |
||
|
研究负责人所在单位: |
新疆维吾尔自治区人民医院 |
||
|
Affiliation of the Leader: |
People's Hospital of Xinjiang Uygur Autonomous Region |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KY2019082101 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
新疆维吾尔自治区人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethic Committee of People's Hospital of Xinjiang Uygur Autonomous Region |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2019-11-06 00:00:00 | ||
|
伦理委员会联系人: |
雷韦 |
||
|
Contact Name of the ethic committee: |
Wei Lei |
||
|
伦理委员会联系地址: |
新疆维吾尔自治区乌鲁木齐市天山区天池路91号 |
||
|
Contact Address of the ethic committee: |
91 Tianchi Road, Tianshan District, Urumqi, Xijiang, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
新疆维吾尔自治区人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
People's Hospital of Xinjiang Uygur Autonomous Region |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
新疆维吾尔自治区乌鲁木齐市天山区天池路91号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
91 Tianchi Road, Tianshan District, Urumqi, Xijiang, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国新生儿协作网 |
||||||||||||||||||||||
|
Source(s) of funding: |
Chinese Neonatal Network |
||||||||||||||||||||||
|
研究疾病: |
新生儿疼痛 |
||||||||||||||||||||||
|
Target disease: |
pain of neonates |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
通过进行多中心随机对照试验,观察在新生儿重症监护室(Neonatal intensive care unit,NICU)进行具有疼痛风险的常规操作时,耳贴磁珠穴位疗法(Magnetic auriculoacupuncture,MA)是否可以降低疼痛评分。 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the efficacy of Magnetic auriculoacupuncture(MA)for reducing pain in infants undergoing standard care for potentially painful routine procedures in the neonatal intensive care unit(NICU). |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1) 已使用镇静剂或阿片类药物; |
||||||||||||||||||||||
|
Exclusion criteria: |
Infants will be excluded if they are receiving sedatives, opioids, or muscle relaxants or are critically ill or dying. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-01-01 00:00:00至 To 2020-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-01-01 00:00:00 至 To 2020-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
使用在奥地利格雷兹医科大学开发的临床试验工具的随机化程序(https://www.randomizer.at/)创建分配方案。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
An allocation scheme will be created using the Randomizer for Clinical Trials tool developed at the Medical University of Graz, Austria (https://www.randomizer.at/). |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
每一个RCT实验均为三盲实验,即只有贴磁珠贴片的临床医师对分组知情,患儿的父母及参与诊疗的医护团队及实验数据登记及分析的研究人员均对分组不知情。记录相关数据的研究实验人员对分组不知情。 |
|
Blinding: |
Each trial in the study will be triple-blinded; thus, only the clinical research fellow placing the magnetic or placebo stickers will be aware if the infant is receiving the intervention, while the parents and the medical and nursing teams caring for the infants and the individuals analyzing the data will all be unaware of the infants study group allocation. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
结题报告,公开发表论文 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Final report,publish papers |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例报告表由统计人员与临床研究管理小组一起设计。所有电子患者身份信息将在一个安全的,受密码保护的数据库上进行,只能由基本人员访问。 具有患者识别信息的纸张形式将在新疆维吾尔自治区人民医院及参与研究的多中心医院限制区内的安全锁定的文件柜中进行。患者只能由代码号识别。 直接访问源数据/文件将需要与试用有关的监控。所有纸张和电子数据将在试验完成后至少保留五年。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The case report form is designed by the statistician and Clinical Research Management Team. All electronic patient identity information will be conducted on a secure, password-protected database and can only be accessed by the basic person. Paper forms with patient identification information will be carried out in a securely locked cabinet in the People's Hospital of Xinjiang Uygur Autonomous Region and multicenter hospitals participating in the study. The patient can only be identified by the code number. Direct access to source data / files will require trial-related monitoring. All paper and electronic data will remain for at least five years after the test is completed. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |